Historique
Rapport
Infections among people who injected drugs in the UK, 2015. An update: November 2016
Titre de série :
Shooting Up
Auteur(s) :
Public Health England ;
Health Protection Scotland ;
Public Health Wales ;
Public Health Agency Northern Ireland
Année
2016
Page(s) :
24 p.
Langue(s) :
Anglais
Éditeur(s) :
London : Public Health England
Refs biblio. :
56
Domaine :
Drogues illicites / Illicit drugs
Discipline :
MAL (Maladies infectieuses / Infectious diseases)
Thésaurus mots-clés
INJECTION
;
CHEMSEX
;
ACTIVITE SEXUELLE
;
USAGER
;
INFECTION
;
BACTERIE
;
VIRUS
;
HEPATITE
;
VIH
;
FACTEUR DE RISQUE
;
PARTAGE DE SERINGUE
;
TYPE D'USAGE
;
DROGUES DE SYNTHESE
;
MEPHEDRONE
;
EVOLUTION
;
AMPHETAMINE
;
SEXUALITE
Thésaurus géographique
ROYAUME-UNI
Résumé :
* HIV levels remain low, but risks continue.
In the UK, around one in 100 people who inject drugs is living with HIV. Most have been diagnosed and will be accessing HIV care. However, HIV is often diagnosed at a late stage among people who inject drugs. HIV transmission continues among people who inject drugs, and both injecting and sexual risks remain common. The emergence of injecting drug use around or during sex among some groups of HIV positive men who have sex with men is a concern, as is the recent HIV outbreak among people injecting heroin in Glasgow.
* Many hepatitis C infections remain undiagnosed.
Hepatitis C remains the most common infection among people who inject drugs, and there are significant levels of transmission among this group in the UK. Two in every five people who inject psychoactive drugs are living with hepatitis C and around half of these infections remain undiagnosed. Around one in 20 of those who inject image and performance-enhancing drugs have hepatitis C.
* Hepatitis B remains rare, but vaccine uptake needs to be sustained.
* Bacterial infections continue to be a problem.
One-third of people who inject psychoactive drugs report having a recent symptom of a bacterial infection. Outbreaks of infections due to bacteria are continuing to occur in this group. Some of these infections are severe and can place substantial demands on the healthcare system.
* Changing patterns of psychoactive drug injection remain a concern.
The increased injection of a range of stimulants, particularly the recently emerged psychoactive drugs such as mephedrone, is a concern. People injecting stimulants often report higher levels of injecting and sexual risk behaviours.
* Provision of effective interventions needs to be maintained.
The provision of effective interventions, which act to reduce risk and prevent infections, needs to be maintained. These interventions include needle and syringe programmes, opioid substitution therapy and other treatments for drug use. Local areas need to be responsive to changes in drug use and risk and offer these interventions in appropriate settings. Vaccinations and diagnostic tests for infections need to be accessible and routinely and regularly offered to people who inject or have previously injected drugs in line with guidance. Care pathways and treatments should be available to those testing positive.
In the UK, around one in 100 people who inject drugs is living with HIV. Most have been diagnosed and will be accessing HIV care. However, HIV is often diagnosed at a late stage among people who inject drugs. HIV transmission continues among people who inject drugs, and both injecting and sexual risks remain common. The emergence of injecting drug use around or during sex among some groups of HIV positive men who have sex with men is a concern, as is the recent HIV outbreak among people injecting heroin in Glasgow.
* Many hepatitis C infections remain undiagnosed.
Hepatitis C remains the most common infection among people who inject drugs, and there are significant levels of transmission among this group in the UK. Two in every five people who inject psychoactive drugs are living with hepatitis C and around half of these infections remain undiagnosed. Around one in 20 of those who inject image and performance-enhancing drugs have hepatitis C.
* Hepatitis B remains rare, but vaccine uptake needs to be sustained.
* Bacterial infections continue to be a problem.
One-third of people who inject psychoactive drugs report having a recent symptom of a bacterial infection. Outbreaks of infections due to bacteria are continuing to occur in this group. Some of these infections are severe and can place substantial demands on the healthcare system.
* Changing patterns of psychoactive drug injection remain a concern.
The increased injection of a range of stimulants, particularly the recently emerged psychoactive drugs such as mephedrone, is a concern. People injecting stimulants often report higher levels of injecting and sexual risk behaviours.
* Provision of effective interventions needs to be maintained.
The provision of effective interventions, which act to reduce risk and prevent infections, needs to be maintained. These interventions include needle and syringe programmes, opioid substitution therapy and other treatments for drug use. Local areas need to be responsive to changes in drug use and risk and offer these interventions in appropriate settings. Vaccinations and diagnostic tests for infections need to be accessible and routinely and regularly offered to people who inject or have previously injected drugs in line with guidance. Care pathways and treatments should be available to those testing positive.
Affiliation :
UK